NCT03368625: A Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases

NCT03368625
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Brain lesions should be between 2-4cm in largest dimension, & require resection
Exclusions: Patients previously treated with WBRT; Patients with leptomeningeal metastasis
https://ClinicalTrials.gov/show/NCT03368625

Comments are closed.

Up ↑